Drug-eluting Balloon vs. Conventional Balloon in the Treatment of (re)Stenosis (Dialysis Fistulae)
DRECOREST2
1 other identifier
interventional
39
0 countries
N/A
Brief Summary
The purpose of this study is to determine whether the use of drug-eluting balloons is effective in the treatment of (re)stenosis in dialysis fistulae.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2013
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 23, 2013
CompletedFirst Submitted
Initial submission to the registry
January 19, 2017
CompletedFirst Posted
Study publicly available on registry
January 30, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2017
CompletedJune 23, 2017
June 1, 2017
4.1 years
January 19, 2017
June 22, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
TLR
Target lesion revascularization, ie. re-intervention to the same lesion
12 months
Occlusion of access
Any loss of dialysis access due to thrombosis
12 months
Secondary Outcomes (2)
Primary assisted patency
12 months
Death
12 months
Study Arms (2)
Drug-eluting balloon
EXPERIMENTALConventional angioplasty
ACTIVE COMPARATORInterventions
Angioplasty with conventional balloon
Angioplasty with drug-eluting balloon
Eligibility Criteria
You may qualify if:
- Any dialysis access w/ native vessels warranting intervention
You may not qualify if:
- Previous PTA with drug-eluting balloon, thrombolysis, coagulopathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Bjorkman P, Weselius EM, Kokkonen T, Rauta V, Alback A, Venermo M. Drug-Coated Versus Plain Balloon Angioplasty In Arteriovenous Fistulas: A Randomized, Controlled Study With 1-Year Follow-Up (The Drecorest Ii-Study). Scand J Surg. 2019 Mar;108(1):61-66. doi: 10.1177/1457496918798206. Epub 2018 Sep 5.
PMID: 30182815DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maarit Venermo, Prof
Helsinki University Hospital, dept of vascular surgery
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Vascular Surgery
Study Record Dates
First Submitted
January 19, 2017
First Posted
January 30, 2017
Study Start
January 23, 2013
Primary Completion
February 28, 2017
Study Completion
February 28, 2017
Last Updated
June 23, 2017
Record last verified: 2017-06
Data Sharing
- IPD Sharing
- Will not share